Safety and tolerability of RYBELSUS were evaluated across 10 different clinical trials 1-4,a Safety and tolerability of RYBELSUS were evaluated across 10 different clinical trials 1-4,a The most frequently reported adverse reactions were GI disorders, including nausea, abdominal pain, and diarrhea Nausea, vomiting, and/or diarrhea occurred mostly during dose escalation 4% and 8% of patients discontinued RYBELSUS 7 mg and 14 mg, respectively, due to GI adverse reactions, compared to 1% of patients receiving placebo GI=gastrointestinal
The venn diagram showed the number of Amplicon Sequence Variants (ASVs) of gut microbiota in the five groups of mice (Figure 5A)
Patients and providers can report side effects to the FDA MedWatch program, which collects safety data
The more consistently you receive IV therapy, the longer-lasting and more pronounced the benefits become
320 , R697R703 (2021)
Youll have the ability to: Message your provider 24/7 via the secure patient portal Adjust your dosage as needed during monthly check-ins Ask questions about new symptoms or side effects Receive real-time guidance if an adverse reaction occurs This level of accessibility ensures that any complications are managed quickly, making the experience safer and more effective than do-it-yourself approaches or unsupervised compounding sources